Reviva Pharmaceuticals (NASDAQ:RVPH) Price Target Cut to $8.00 by Analysts at D. Boral Capital
Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) had its price objective lowered by equities research analysts at D. Boral Capital from $15.00 to $8.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. A number of other equities research analysts have also recently weighed in on the […]
Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) had its price objective lowered by equities research analysts at D. Boral Capital from $15.00 to $8.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. A number of other equities research analysts have also recently weighed in on the […]
